annual current liabilities:
$2.21B-$809.00M(-26.83%)Summary
- As of today (May 21, 2025), MRNA annual total current liabilities is $2.21 billion, with the most recent change of -$809.00 million (-26.83%) on December 31, 2024.
- During the last 3 years, MRNA annual current liabilities has fallen by -$6.92 billion (-75.83%).
- MRNA annual current liabilities is now -75.83% below its all-time high of $9.13 billion, reached on December 31, 2021.
Performance
MRNA Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.60B-$602.00M(-27.29%)Summary
- As of today (May 21, 2025), MRNA quarterly total current liabilities is $1.60 billion, with the most recent change of -$602.00 million (-27.29%) on March 31, 2025.
- Over the past year, MRNA quarterly current liabilities has dropped by -$776.00 million (-32.61%).
- MRNA quarterly current liabilities is now -83.89% below its all-time high of $9.96 billion, reached on September 30, 2021.
Performance
MRNA quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MRNA Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | -32.6% |
| 3 y3 years | -75.8% | -82.6% |
| 5 y5 years | +1441.4% | +1091.8% |
MRNA Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -82.6% | at low |
| 5 y | 5-year | -75.8% | +1441.4% | -83.9% | +1091.8% |
| alltime | all time | -75.8% | >+9999.0% | -83.9% | >+9999.0% |
MRNA Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.60B(-27.3%) |
| Dec 2024 | $2.21B(-26.8%) | $2.21B(+0.2%) |
| Sep 2024 | - | $2.20B(-6.9%) |
| Jun 2024 | - | $2.36B(-0.7%) |
| Mar 2024 | - | $2.38B(-21.1%) |
| Dec 2023 | $3.02B(-38.8%) | $3.02B(-31.2%) |
| Sep 2023 | - | $4.38B(+40.4%) |
| Jun 2023 | - | $3.12B(-10.7%) |
| Mar 2023 | - | $3.50B(-28.9%) |
| Dec 2022 | $4.92B(-46.1%) | $4.92B(-27.7%) |
| Sep 2022 | - | $6.81B(-0.1%) |
| Jun 2022 | - | $6.81B(-26.3%) |
| Mar 2022 | - | $9.24B(+1.2%) |
| Dec 2021 | $9.13B(+108.0%) | $9.13B(-8.3%) |
| Sep 2021 | - | $9.96B(+12.6%) |
| Jun 2021 | - | $8.84B(+4.7%) |
| Mar 2021 | - | $8.44B(+92.3%) |
| Dec 2020 | $4.39B(+2966.8%) | $4.39B(+197.8%) |
| Sep 2020 | - | $1.47B(+811.6%) |
| Jun 2020 | - | $161.65M(+20.1%) |
| Mar 2020 | - | $134.58M(-6.0%) |
| Dec 2019 | $143.12M(-35.8%) | $143.12M(-3.2%) |
| Sep 2019 | - | $147.84M(-8.7%) |
| Jun 2019 | - | $161.99M(+1.8%) |
| Mar 2019 | - | $159.16M(-28.6%) |
| Dec 2018 | $222.80M(+16.4%) | $222.80M(+19.5%) |
| Sep 2018 | - | $186.42M(-2.6%) |
| Dec 2017 | $191.46M(+17.6%) | $191.46M(+4049.1%) |
| Sep 2017 | - | $4.61M(+11.0%) |
| Jun 2017 | - | $4.16M(+54.1%) |
| Mar 2017 | - | $2.70M(-9.1%) |
| Dec 2016 | $162.80M(+6583.2%) | - |
| Dec 2016 | - | $2.97M(-1.3%) |
| Sep 2016 | - | $3.01M(-3.2%) |
| Jun 2016 | - | $3.11M(+9.1%) |
| Mar 2016 | - | $2.85M(+17.0%) |
| Dec 2015 | $2.44M(+25.4%) | $2.44M(-2.3%) |
| Sep 2015 | - | $2.49M(+17.5%) |
| Jun 2015 | - | $2.12M(+14.3%) |
| Mar 2015 | - | $1.86M(-4.4%) |
| Dec 2014 | $1.94M(-68.8%) | $1.94M(-14.8%) |
| Sep 2014 | - | $2.28M(+12.6%) |
| Jun 2014 | - | $2.02M(-25.1%) |
| Mar 2014 | - | $2.70M(-56.5%) |
| Dec 2013 | $6.22M(+10.5%) | $6.22M(+7.3%) |
| Sep 2013 | - | $5.79M(+3.8%) |
| Jun 2013 | - | $5.58M(+2.9%) |
| Mar 2013 | - | $5.43M(-3.6%) |
| Dec 2012 | $5.63M(+21.3%) | $5.63M(+1.6%) |
| Sep 2012 | - | $5.54M(-13.4%) |
| Jun 2012 | - | $6.40M(+14.2%) |
| Mar 2012 | - | $5.60M(+20.8%) |
| Dec 2011 | $4.64M(-26.1%) | $4.64M(+8.3%) |
| Sep 2011 | - | $4.28M(-38.0%) |
| Jun 2011 | - | $6.91M(+9.4%) |
| Mar 2011 | - | $6.32M(+0.7%) |
| Dec 2010 | $6.27M(+22.3%) | $6.27M(+22.3%) |
| Sep 2010 | - | $5.13M(-38.2%) |
| Jun 2010 | - | $8.30M(+56.4%) |
| Mar 2010 | - | $5.31M(+3.5%) |
| Dec 2009 | $5.13M | $5.13M(+40.7%) |
| Sep 2009 | - | $3.65M(+4.2%) |
| Jun 2009 | - | $3.50M(-50.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $7.05M(-43.7%) |
| Dec 2008 | $12.52M(-7.7%) | $12.52M(+14.8%) |
| Sep 2008 | - | $10.91M(+10.3%) |
| Jun 2008 | - | $9.89M(-15.9%) |
| Mar 2008 | - | $11.76M(-13.3%) |
| Dec 2007 | $13.57M(-7.9%) | $13.57M(-9.5%) |
| Sep 2007 | - | $14.99M(+11.3%) |
| Jun 2007 | - | $13.47M(-1.1%) |
| Mar 2007 | - | $13.62M(-7.5%) |
| Dec 2006 | $14.72M(+60.4%) | $14.72M(+5.5%) |
| Sep 2006 | - | $13.96M(+11.5%) |
| Jun 2006 | - | $12.52M(+11.4%) |
| Mar 2006 | - | $11.24M(+22.5%) |
| Dec 2005 | $9.18M(-45.5%) | $9.18M(+3.1%) |
| Sep 2005 | - | $8.90M(-15.0%) |
| Jun 2005 | - | $10.47M(+17.2%) |
| Mar 2005 | - | $8.94M(-46.9%) |
| Dec 2004 | $16.84M(+52.2%) | $16.84M(+15.2%) |
| Sep 2004 | - | $14.62M(+11.2%) |
| Jun 2004 | - | $13.14M(+3.1%) |
| Mar 2004 | - | $12.75M(+15.2%) |
| Dec 2003 | $11.07M(+56.7%) | $11.07M(-7.3%) |
| Sep 2003 | - | $11.94M(-3.7%) |
| Jun 2003 | - | $12.41M(-8.1%) |
| Mar 2003 | - | $13.50M(+91.2%) |
| Dec 2002 | $7.06M(+268.6%) | $7.06M(-17.2%) |
| Sep 2002 | - | $8.53M(+80.0%) |
| Jun 2002 | - | $4.74M(+28.9%) |
| Mar 2002 | - | $3.68M(+91.9%) |
| Dec 2001 | $1.92M(-8.6%) | $1.92M(+6.9%) |
| Sep 2001 | - | $1.79M(-4.0%) |
| Jun 2001 | - | $1.87M(-15.1%) |
| Mar 2001 | - | $2.20M(+4.8%) |
| Dec 2000 | $2.10M(-41.8%) | $2.10M(-12.2%) |
| Sep 2000 | - | $2.39M(-0.0%) |
| Jun 2000 | - | $2.39M(+26.2%) |
| Mar 2000 | - | $1.89M(-47.4%) |
| Dec 1999 | $3.60M(+80.0%) | $3.60M(+44.0%) |
| Sep 1999 | - | $2.50M(+25.0%) |
| Jun 1999 | - | $2.00M(-13.0%) |
| Mar 1999 | - | $2.30M(+15.0%) |
| Dec 1998 | $2.00M(-16.7%) | $2.00M(-4.8%) |
| Sep 1998 | - | $2.10M(-4.5%) |
| Jun 1998 | - | $2.20M(+29.4%) |
| Mar 1998 | - | $1.70M(-29.2%) |
| Dec 1997 | $2.40M(+118.2%) | $2.40M(+33.3%) |
| Sep 1997 | - | $1.80M(+5.9%) |
| Jun 1997 | - | $1.70M(+21.4%) |
| Mar 1997 | - | $1.40M(+55.6%) |
| Dec 1996 | $1.10M(-35.3%) | - |
| Sep 1996 | - | $900.00K(-47.1%) |
| Jun 1996 | $1.70M(0.0%) | $1.70M(+30.8%) |
| Mar 1996 | - | $1.30M(0.0%) |
| Dec 1995 | - | $1.30M(-13.3%) |
| Sep 1995 | - | $1.50M(-11.8%) |
| Jun 1995 | $1.70M(+41.7%) | $1.70M(+41.7%) |
| Mar 1995 | - | $1.20M(+9.1%) |
| Dec 1994 | - | $1.10M(-8.3%) |
| Sep 1994 | - | $1.20M(0.0%) |
| Jun 1994 | $1.20M | $1.20M(+20.0%) |
| Mar 1994 | - | $1.00M(-9.1%) |
| Dec 1993 | - | $1.10M(+10.0%) |
| Sep 1993 | - | $1.00M |
FAQ
- What is Moderna annual total current liabilities?
- What is the all time high annual current liabilities for Moderna?
- What is Moderna annual current liabilities year-on-year change?
- What is Moderna quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Moderna?
- What is Moderna quarterly current liabilities year-on-year change?
What is Moderna annual total current liabilities?
The current annual current liabilities of MRNA is $2.21B
What is the all time high annual current liabilities for Moderna?
Moderna all-time high annual total current liabilities is $9.13B
What is Moderna annual current liabilities year-on-year change?
Over the past year, MRNA annual total current liabilities has changed by -$809.00M (-26.83%)
What is Moderna quarterly total current liabilities?
The current quarterly current liabilities of MRNA is $1.60B
What is the all time high quarterly current liabilities for Moderna?
Moderna all-time high quarterly total current liabilities is $9.96B
What is Moderna quarterly current liabilities year-on-year change?
Over the past year, MRNA quarterly total current liabilities has changed by -$776.00M (-32.61%)